image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Judges Scientific - Eps to be ahead of expectations

February 2022

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • JDG
  • Price:
  • 856p
Thanks to strong organic order intake (organic order book +25.1% versus FY’20), Judges has announced it anticipates full year eps to be ahead of expectations. Broker Shore Capital has increased eps forecasts by 10% to 233p for 2021, with FY’22 upped by 3% to 242p, although it will review its forecast model in greater detail in March. The broker expects Judges to have nominal debt of c. £5.4m so more deals are likely. A pleasant upgrade just two months after my main write-up. Unsurprisingly, I am still a buyer. ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X